cabergoline has been researched along with Peritoneal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kogan, I; Molotkov, A; Suslova, E; Tkachenko, N; Yarmolinskaya, M | 1 |
| Bougeret, C; Corachán, A; Domínguez, F; Ferrero, H; Pellicer, A; Pouletty, P; Quiñonero, A | 1 |
| Carda, C; Herraiz, S; Novella-Maestre, E; Pellicer, A; Ruiz-Sauri, A; Vila-Vives, JM | 1 |
1 trial(s) available for cabergoline and Peritoneal Diseases
| Article | Year |
|---|---|
Dopamine agonists as genital endometriosis target therapy.
Topics: Adult; Ascitic Fluid; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Molecular Targeted Therapy; Pelvic Pain; Peritoneal Diseases; Prolactin; Russia; Syndrome; Treatment Outcome | 2020 |
2 other study(ies) available for cabergoline and Peritoneal Diseases
| Article | Year |
|---|---|
Inhibition of KIF20A by BKS0349 reduces endometriotic lesions in a xenograft mouse model.
Topics: Animals; Apoptosis; Cabergoline; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Heterografts; Humans; Kinesins; Mice; Mice, Nude; Optical Imaging; Peritoneal Diseases | 2019 |
Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
Topics: Actins; Angiogenesis Inhibitors; Animals; Biomarkers; Cabergoline; Disease Models, Animal; Endometriosis; Endometrium; Ergolines; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Macrophages; Mast Cells; Mice; Mice, Nude; Microvessels; Neovascularization, Pathologic; Nerve Fibers; Ovariectomy; Peritoneal Diseases; Time Factors; von Willebrand Factor | 2012 |